Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Jan;51(1):139–141. doi: 10.1136/jnnp.51.1.139

Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis.

A D Crockard 1, T A McNeill 1, J McKirgan 1, S A Hawkins 1
PMCID: PMC1032729  PMID: 2965217

Abstract

Using monoclonal antibodies Ta1 and CD25 (interleukin-2 receptor: I-2R) and flow cytometry, the levels of activated lymphocytes in the peripheral blood of 50 patients with multiple sclerosis (16 relapsing inactive; 14 relapsing active; 20 chronic progressive) and 20 normal subjects were investigated. No significant differences were observed in the percentage or absolute numbers of Ta1 and IL-2R reactive lymphocytes between the normal and multiple sclerosis patient groups, irrespective of disease activity. Monitoring peripheral blood lymphocytes with respect to these markers would appear to have little value in the management of multiple sclerosis.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. A., Phan-Dinh-Tuy F., Tournier E., Chatenoud L., Bach J. F., Martin C., Degos J. D. Deficit of suppressor T cells in active multiple sclerosis. Lancet. 1980 Dec 6;2(8206):1221–1223. doi: 10.1016/s0140-6736(80)92480-0. [DOI] [PubMed] [Google Scholar]
  2. Bellamy A. S., Calder V. L., Feldmann M., Davison A. N. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes. Clin Exp Immunol. 1985 Aug;61(2):248–256. [PMC free article] [PubMed] [Google Scholar]
  3. Fox D. A., Hussey R. E., Fitzgerald K. A., Acuto O., Poole C., Palley L., Daley J. F., Schlossman S. F., Reinherz E. L. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol. 1984 Sep;133(3):1250–1256. [PubMed] [Google Scholar]
  4. Fredrikson S., Karlsson-Parra A., Olsson T., Link H. HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis. Clin Exp Immunol. 1987 May;68(2):298–304. [PMC free article] [PubMed] [Google Scholar]
  5. Golaz J., Steck A., Moretta L. Activated T lymphocytes in patients with multiple sclerosis. Neurology. 1983 Oct;33(10):1371–1373. doi: 10.1212/wnl.33.10.1371. [DOI] [PubMed] [Google Scholar]
  6. Hafler D. A., Fox D. A., Benjamin D., Weiner H. L. Antigen reactive memory T cells are defined by Ta1. J Immunol. 1986 Jul 15;137(2):414–418. [PubMed] [Google Scholar]
  7. Hafler D. A., Fox D. A., Manning M. E., Schlossman S. F., Reinherz E. L., Weiner H. L. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med. 1985 May 30;312(22):1405–1411. doi: 10.1056/NEJM198505303122201. [DOI] [PubMed] [Google Scholar]
  8. Hafler D. A., Hemler M. E., Christenson L., Williams J. M., Shapiro H. M., Strom T. B., Strominger J. L., Weiner H. L. Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. Clin Immunol Immunopathol. 1985 Nov;37(2):163–171. doi: 10.1016/0090-1229(85)90147-3. [DOI] [PubMed] [Google Scholar]
  9. McDonald W. I., Halliday A. M. Diagnosis and classification of multiple sclerosis. Br Med Bull. 1977 Jan;33(1):4–9. [PubMed] [Google Scholar]
  10. Paty D. W., Kastrukoff L., Morgan N., Hiob L. Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease. Ann Neurol. 1983 Oct;14(4):445–449. doi: 10.1002/ana.410140408. [DOI] [PubMed] [Google Scholar]
  11. Rice G. P., Finney D., Braheny S. L., Knobler R. L., Sipe J. C., Oldstone M. B. Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8. J Neuroimmunol. 1984 Apr;6(2):75–84. doi: 10.1016/0165-5728(84)90028-6. [DOI] [PubMed] [Google Scholar]
  12. Selmaj K., Plater-Zyberk C., Rockett K. A., Maini R. N., Alam R., Perkin G. D., Rose F. C. Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes. Neurology. 1986 Oct;36(10):1392–1395. doi: 10.1212/wnl.36.10.1392. [DOI] [PubMed] [Google Scholar]
  13. Thompson A. J., Brazil J., Whelan C. A., Martin E. A., Hutchinson M., Feighery C. Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse? J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):905–912. doi: 10.1136/jnnp.49.8.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tournier-Lasserve E., Lyoncaen O., Roullet E., Bach M. A. IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. Clin Exp Immunol. 1987 Mar;67(3):581–586. [PMC free article] [PubMed] [Google Scholar]
  15. Weiner H. L., Hafler D. A., Fallis R. J., Johnson D., Ault K. A., Hauser S. L. Altered blood T-cell subsets in patients with multiple sclerosis. J Neuroimmunol. 1984 Apr;6(2):115–121. doi: 10.1016/0165-5728(84)90032-8. [DOI] [PubMed] [Google Scholar]
  16. Zabriskie J. B., Mayer L., Fu S. M., Yeadon C., Cam V., Plank C. T-cell subsets in multiple sclerosis: lack of correlation between helper and suppressor T cells and the clinical state. J Clin Immunol. 1985 Jan;5(1):7–12. doi: 10.1007/BF00915162. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES